ResearcherWuhan Union HospitalActive in the last 2 years

Chen Zhou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7659-8083; OpenAlex author ID A5100643854. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

MMP28 recruits M2-type tumor-associated macrophages through MAPK/JNK signaling pathway-dependent cytokine secretion to promote the malignant progression of pan… Co-author DOI 10.1186/s13046-025-03321-x ↗
Integrated analysis of scRNA-seq and bulk RNA-seq reveals that GPRC5A is an important prognostic gene in pancreatic cancer and is associated with B-cell Infilt… Co-author DOI 10.3389/fonc.2024.1283164 ↗
ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.215855 ↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shi Dong · 1 shared paper, 2025 · strength 0.30
- Paper MMP28 recruits M2-type tumor-associated macrophages through MAPK/JNK signaling pathway-dependent cytokine secretion to … DOI 10.1186/s13046-025-03321-x ↗
Huaqing Shi · 1 shared paper, 2025 · strength 0.30
- Paper MMP28 recruits M2-type tumor-associated macrophages through MAPK/JNK signaling pathway-dependent cytokine secretion to … DOI 10.1186/s13046-025-03321-x ↗
Xin Li · 1 shared paper, 2025 · strength 0.30
- Paper MMP28 recruits M2-type tumor-associated macrophages through MAPK/JNK signaling pathway-dependent cytokine secretion to … DOI 10.1186/s13046-025-03321-x ↗
Wence Zhou · 1 shared paper, 2025 · strength 0.30
- Paper MMP28 recruits M2-type tumor-associated macrophages through MAPK/JNK signaling pathway-dependent cytokine secretion to … DOI 10.1186/s13046-025-03321-x ↗
Chunlu Dong · 1 shared paper, 2024 · strength 0.20
- Paper Integrated analysis of scRNA-seq and bulk RNA-seq reveals that GPRC5A is an important prognostic gene in pancreatic can… DOI 10.3389/fonc.2024.1283164 ↗
Fangfang Han · 1 shared paper, 2024 · strength 0.20
- Paper Integrated analysis of scRNA-seq and bulk RNA-seq reveals that GPRC5A is an important prognostic gene in pancreatic can… DOI 10.3389/fonc.2024.1283164 ↗
Wence Zhou · 1 shared paper, 2024 · strength 0.20
- Paper Integrated analysis of scRNA-seq and bulk RNA-seq reveals that GPRC5A is an important prognostic gene in pancreatic can… DOI 10.3389/fonc.2024.1283164 ↗
Yingke Zhou · 1 shared paper, 2022 · strength 0.14
- Paper ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer. DOI 10.1016/j.canlet.2022.215855 ↗
Penglin Pan · 1 shared paper, 2022 · strength 0.14
- Paper ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer. DOI 10.1016/j.canlet.2022.215855 ↗
Gengdu Qin · 1 shared paper, 2022 · strength 0.14
- Paper ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer. DOI 10.1016/j.canlet.2022.215855 ↗
Heshui Wu · 1 shared paper, 2022 · strength 0.14
- Paper ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer. DOI 10.1016/j.canlet.2022.215855 ↗
Dianyun Ren · 1 shared paper, 2022 · strength 0.14
- Paper ITGA2 overexpression inhibits DNA repair and confers sensitivity to radiotherapies in pancreatic cancer. DOI 10.1016/j.canlet.2022.215855 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.